The haptoglobin-cd163-heme oxygenase-1 pathway for hemoglobin scavenging

Oxidative Medicine and Cellular Longevity

Volumn , Issue , 2013, Pages

  Thomsen, Jens Haugbølle ^a   Etzerodt, Anders ^a   Svendsen, Pia ^a   Moestrup, Søren K ^a  

^a AARHUS UNIVERSITY   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI-INFLAMMATORIES; ANTI-INFLAMMATORY EFFECTS; ANTI-INFLAMMATORY RESPONSE; HEME OXYGENASE-1; INTERLEUKIN-6; PLASMA CONCENTRATION; REGULATORY FACTORS; UP-REGULATION;

CARBON MONOXIDE; HEMOGLOBIN; METABOLITES; PATHOLOGY; PIGMENTS; TOXICITY;

PORPHYRINS;

BILIRUBIN; CD163 ANTIGEN; GAMMA INTERFERON; HAPTOGLOBIN; HEME; HEME OXYGENASE 1; HEMOGLOBIN; HEMOPEXIN; INTERLEUKIN 1; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; TRANSCRIPTION FACTOR NRF2; CELL SURFACE RECEPTOR; DIFFERENTIATION ANTIGEN; LEUKOCYTE ANTIGEN;

ANGIOGENESIS; ANTIINFLAMMATORY ACTIVITY; DOWN REGULATION; HEMOLYSIS; HUMAN; INFLAMMATION; LIVER CELL; NONHUMAN; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION; UPREGULATION; ANIMAL; CHEMISTRY; METABOLISM; PROTEIN BINDING;

ANIMALIA;

ANIMALS; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; HAPTOGLOBINS; HEME; HEME OXYGENASE-1; HEMOGLOBINS; HUMANS; PROTEIN BINDING; RECEPTORS, CELL SURFACE;

EID: 84879382021     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2013/523652     Document Type: Review

References (125)

1. Bratosin D., Mazurier J., Tissier J. P., Estaquier J., Huart J. J., Ameisen J. C., Aminoff D., Montreuil J., Cellular and molecular mechanisms of senescent erythrocyte phagocytosis by macrophages. A review. Biochimie 1998 80 2 173 195 2-s2.0-0032006450 10.1016/S0300-9084(98)80024-2
2. Straat M., van Bruggen R., de Korte D., Juffermans N. P., Red blood cell clearance in inflammation. Transfusion Medicine and Hemotherapy 2012 39 5 353 360 10.1159/000342229
3. Rother R. P., Bell L., Hillmen P., Gladwin M. T., The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: a novel mechanism of human disease. Journal of the American Medical Association 2005 293 13 1653 1662 2-s2.0-15944398355 10.1001/jama.293.13.1653
4. Aronowski J., Zhao X., Molecular pathophysiology of cerebral hemorrhage: secondary brain injury. Stroke 2011 42 6 1781 1786 2-s2.0-79958255054 10.1161/STROKEAHA.110.596718
5. Levy A. P., Asleh R., Blum S., Levy N. S., Miller-Lotan R., Kalet-Litman S., Anbinder Y., Lache O., Nakhoul F. M., Asaf R., Farbstein D., Pollak M., Soloveichik Y. Z., Strauss M., Alshiek J., Livshits A., Schwartz A., Awad H., Jad K., Goldenstein H., Haptoglobin: basic and clinical aspects. Antioxidants and Redox Signaling 2010 12 2 293 304 2-s2.0-77949521505 10.1089/ars.2009.2793
6. Theilgaard-Mönch K., Jacobsen L. C., Nielsen M. J., Rasmussen T., Udby L., Gharib M., Arkwright P. D., Gombart A. F., Calafat J., Moestrup S. K., Porse B. T., Borregaard N., Haptoglobin is synthesized during granulocyte differentiation, stored in specific granules, and released by neutrophils in response to activation. Blood 2006 108 1 353 361 2-s2.0-33745624575 10.1182/blood-2005-09-3890
7. Andersen C. B., Torvund-Jensen M., Nielsen M. J., Structure of the haptoglobin-haemoglobin complex. Nature 2012 489 7416 456 459
8. Wicher K. B., Fries E., Evolutionary aspects of hemoglobin scavengers. Antioxidants and Redox Signaling 2010 12 2 249 260 2-s2.0-77949497125 10.1089/ars.2009.2760
9. Nielsen M. J., Moestrup S. K., Receptor targeting of hemoglobin mediated by the haptoglobins: roles beyond heme scavenging. Blood 2009 114 4 764 771 2-s2.0-68249147985 10.1182/blood-2009-01-198309
10. Bode J. G., Albrecht U., Haussinger D., Heinrich P. C., Schaper F., Hepatic acute phase proteins-regulation by IL- and IL-1-type cytokines involving STAT3 and its crosstalk with NF-kappaB-dependent signaling. European Journal of Cell Biology 2012 91 6-7 6496 6505
11. Alayash A. I., Andersen C. B., Moestrup S. K., Bülow L., Haptoglobin: the hemoglobin detoxifier in plasma. Trends in Biotechnology 2013 31 1 2 3
12. Wobeto V. P. D. A., Zaccariotto T. R., Sonati M. D. F., Polymorphism of human haptoglobin and its clinical importance. Genetics and Molecular Biology 2008 31 3 602 620 2-s2.0-55349091326
13. Etzerodt A., Moestrup S. K., CD163 and inflammation: biological, diagnostic and therapeutic aspects. Antioxid Redox Signal 2012 18 17 2352 2363
14. Banerjee S., Jia Y., Siburt C. J. P., Haptoglobin alters oxygenation and oxidation of hemoglobin and decreases propagation of peroxide-induced oxidative reactions. Free Radical Biology and Medicine 2012 53 6 1317 1326
15. Buehler P. W., Abraham B., Vallelian F., Linnemayr C., Pereira C. P., Cipollo J. F., Jia Y., Mikolajczyk M., Boretti F. S., Schoedon G., Alayash A. I., Schaer D. J., Haptoglobin preserves the CD163 hemoglobin scavenger pathway by shielding hemoglobin from peroxidative modification. Blood 2009 113 11 2578 2586 2-s2.0-63849094585 10.1182/blood-2008-08-174466
16. Tolosano E., Fagoonee S., Morello N., Vinchi F., Fiorito V., Heme scavenging and the other facets of hemopexin. Antioxidants and Redox Signaling 2010 12 2 305 320 2-s2.0-77949497609 10.1089/ars.2009.2787
17. Azarov I., He X., Jeffers A., Basu S., Ucer B., Hantgan R. R., Levy A., Kim-Shapiro D. B., Rate of nitric oxide scavenging by hemoglobin bound to haptoglobin. Nitric Oxide 2008 18 4 296 302 2-s2.0-42749092733 10.1016/j.niox.2008.02.006
18. Kristiansen M., Graversen J. H., Jacobsen C., Sonne O., Hoffman H. J., Law S. K. A., Moestrup S. K., Identification of the haemoglobin scavenger receptor. Nature 2001 409 6817 198 201 2-s2.0-0035843134 10.1038/35051594
19. Nielsen M. J., Petersen S. V., Jacobsen C., Thirup S., Enghild J. J., Graversen J. H., Moestrup S. K., A unique loop extension in the serine protease domain of haptoglobin is essential for CD163 recognition of the haptoglobin-hemoglobin complex. Journal of Biological Chemistry 2007 282 2 1072 1079 2-s2.0-33847749415 10.1074/jbc.M605684200
20. Nielsen M. J., Andersen C. B. F., Moestrup S. K., CD163 binding to haptoglobin-hemoglobin complexes involves a dual-point electrostatic receptor-ligand pairing. Journal of Biological Chemistry 2013 10.1074/jbc.M113.471060
21. Levy A. P., Hochberg I., Jablonski K., Resnick H. E., Lee E. T., Best L., Howard B. V., Haptoglobin phenotype is an independent risk factor for cardiovascular disease in individuals with diabetes: the strong heart study. Journal of the American College of Cardiology 2002 40 11 1984 1990 2-s2.0-0037021557 10.1016/S0735-1097(02)02534-2
22. Levy A. P., Blum S., Vardi M., Brown J. B., Russell A., Milman U., Shapira C., Levy N. S., Miller-Lotan R., Asleh R., Vitamin e reduces cardiovascular disease in individuals with diabetes mellitus and the haptoglobin 2-2 genotype. Pharmacogenomics 2010 11 5 675 684 2-s2.0-77951529201 10.2217/pgs.10.17
23. Elagib A. A., Kider A. O., Åkerström B., Elbashir M. I., Association of the haptoglobin phenotype (1-1) with falciparum malaria in Sudan. Transactions of the Royal Society of Tropical Medicine and Hygiene 1998 92 3 309 311 2-s2.0-0031805243 10.1016/S0035-9203(98)91025-2
24. Quaye I. K., Ekuban F. A., Goka B. Q., Haptoglobin 1-1 is associated with susceptibility to severe Plasmodium falciparum malaria. Transactions of the Royal Society of Tropical Medicine and Hygiene 2000 94 2 216 219
25. Cunnington A. J., Njie M., Correa S., Takem E. N., Riley E. M., Walther M., Prolonged neutrophil dysfunction after Plasmodium falciparum malaria is related to hemolysis and heme oxygenase-1 induction. Journal of Immunology 2012 189 11 5336 5346 10.4049/jimmunol.1201028
26. Mendonca V. R., Luz N. F., Santos N. J. G., Association between the haptoglobin and heme oxygenase 1 genetic profiles and soluble CD163 in susceptibility to and severity of human malaria. Infection and Immunity 2012 80 4 1445 1454 10.1128/IAI.05933-11
27. Quaye I., Haptoglobin genotypes are not associated with resistance to severe malaria in The Gambia. Transactions of the Royal Society of Tropical Medicine and Hygiene 2003 97 1 121
28. Beiguelman B., Alves F. P., Moura M. M., Engracia V., Nunes A. C. S., Heckmann M. I. O., Ferreira R. G. M., Pereira Da Silva L. H., Camargo E. P., Krieger H., The association of genetic markers and malaria infection in the Brazilian Western Amazonian region. Memorias do Instituto Oswaldo Cruz 2003 98 4 455 460 2-s2.0-0142214442
29. Freeman M., Ashkenas J., Rees D. J. G., Kingsley D. M., Copeland N. G., Jenkins N. A., Krieger M., An ancient, highly conserved family of cysteine-rich protein domains revealed by cloning type I and type II murine macrophage scavenger receptors. Proceedings of the National Academy of Sciences of the United States of America 1990 87 22 8810 8814 2-s2.0-0025253834 10.1073/pnas.87.22.8810
30. Rodamilans B., Muñoz I. G., Bragado-Nilsson E., Sarrias M. R., Padilla O., Blanco F. J., Lozano F., Montoya G., Crystal structure of the third extracellular domain of CD5 reveals the fold of a group B scavenger cysteine-rich receptor domain. Journal of Biological Chemistry 2007 282 17 12669 12677 2-s2.0-34250378347 10.1074/jbc.M611699200
31. Hohenester E., Sasaki T., Timpl R., Crystal structure of a scavenger receptor cysteine-rich domain sheds light on an ancient superfamily. Nature Structural Biology 1999 6 3 228 232 2-s2.0-0033006297 10.1038/6669
32. Somoza J. R., Ho J. D., Luong C., Ghate M., Sprengeler P. A., Mortara K., Shrader W. D., Sperandio D., Chan H., McGrath M. E., Katz B. A., The structure of the extracellular region of human hepsin reveals a serine protease domain and a novel scavenger receptor cysteine-rich (SRCR) domain. Structure 2003 11 9 1123 1131 2-s2.0-12444316010 10.1016/S0969-2126(03)00148-5
33. Martínez V. G., Moestrup S. K., Holmskov U., Mollenhauer J., Lozano F., The conserved scavenger receptor cysteine-rich super family in therapy and diagnosis. Pharmacological Reviews 2011 63 4 967 1000 2-s2.0-80053612895 10.1124/pr.111.004523
34. Van Gorp H., Delputte P. L., Nauwynck H. J., Scavenger receptor CD163, a Jack-of-all-trades and potential target for cell-directed therapy. Molecular Immunology 2010 47 7-8 1650 1660 2-s2.0-77950627035 10.1016/j.molimm.2010.02.008
35. Ritter M., Buechler C., Langmann T., Orso E., Klucken J., Schmitz G., The scavenger receptor CD163: regulation, promoter structure and genomic organization. Pathobiology 2000 67 5-6 257 261 2-s2.0-0342905414
36. Ritter M., Buechler C., Kapinsky M., Schmitz G., Interaction of CD163 with the regulatory subunit of casein kinase II (CKII) and dependence of CD163 signaling on CKII and protein kinase C. European Journal of Immunology 2001 31 4 999 1009
37. Nielsen M. J., Madsen M., Møller H. J., Moestrup S. K., The macrophage scavenger receptor CD163: endocytic properties of cytoplasmic tail variants. Journal of Leukocyte Biology 2006 79 4 837 845 2-s2.0-33745859724 10.1189/jlb.1005602
38. Maniecki M. B., Møller H. J., Moestrup S. K., Møller B. K., CD163 positive subsets of blood dendritic cells: the scavenging macrophage receptors CD163 and CD91 are coexpressed on human dendritic cells and monocytes. Immunobiology 2006 211 6-8 407 417 2-s2.0-33747338455 10.1016/j.imbio.2006.05. 019
39. Kodelja V., Goerdt S., Dissection of macrophage differentiation pathways in cutaneous macrophage disorders and in vitro. Experimental Dermatology 1994 3 6 257 268 2-s2.0-0028577734 10.1111/j.1600-0625.1994.tb00287.x
40. Zwadlo-Klarwasser G., Bent S., Haubeck H. D., Sorg C., Schmutzler W., Glucocorticoid-induced appearance of the macrophage subtype RM 3/1 in peripheral blood of man. International Archives of Allergy and Applied Immunology 1990 91 2 175 180 2-s2.0-0025288548
41. Kamimura D., Ishihara K., Hirano T., IL-6 signal transduction and its physiological roles: the signal orchestration model. Reviews of Physiology, Biochemistry and Pharmacology 2003 149 1 38 2-s2.0-1542297244
42. Gordon S., Martinez F. O., Alternative activation of macrophages: mechanism and functions. Immunity 2010 32 5 593 604 2-s2.0-77953268611 10.1016/j.immuni.2010.05.007
43. Zwadlo G., Voegeli R., Schulze Osthoff K., Sorg C., A monoclonal antibody to a novel differentiation antigen on human macrophages associated with the down-regulatory phase of the inflammatory process. Experimental Cell Biology 1987 55 6 295 304 2-s2.0-0023576184
44. Finn A. V., Nakano M., Polavarapu R., Hemoglobin directs macrophage differentiation and prevents foam cell formation in human atherosclerotic plaques. Journal of the American College of Cardiology 2012 59 2 166 177
45. Boyle J. J., Heme and haemoglobin direct macrophage Mhem phenotype and counter foam cell formation in areas of intraplaque haemorrhage. Current Opinion in Lipidology 2012 23 5 453 461
46. Moller H. J., Soluble CD163. Scandinavian Journal of Clinical & Laboratory Investigation 2012 72 1 1 13
47. Etzerodt A., Maniecki M. B., Møller K., Møller H. J., Moestrup S. K., Tumor necrosis factor converting enzyme (TACE/ADAM17) mediates ectodomain shedding of the scavenger receptor CD163. Journal of Leukocyte Biology 2010 88 6 1201 1205 2-s2.0-78649729313 10.1189/jlb.0410235
48. Kneidl J., Löffler B., Erat M. C., Kalinka J., Peters G., Roth J., Barczyk K., Soluble CD163 promotes recognition, phagocytosis and killing of Staphylococcus aureus via binding of specific fibronectin peptides. Cellular Microbiology 2012 14 6 914 936
49. Baeten D., Møller H. J., Delanghe J., Veys E. M., Moestrup S. K., De Keyser F., Association of CD163+ macrophages and local production of soluble CD163 with decreased lymphocyte activation in spondylarthropathy synovitis. Arthritis and Rheumatism 2004 50 5 1611 1623 2-s2.0-2342555072 10.1002/art.20174
50. Moreno J. A., Muñoz-García B., Martín-Ventura J. L., Madrigal-Matute J., Orbe J., Páramo J. A., Ortega L., Egido J., Blanco-Colio L. M., The CD163-expressing macrophages recognize and internalize TWEAK. Potential consequences in atherosclerosis. Atherosclerosis 2009 207 1 103 110 2-s2.0-70350444860 10.1016/j.atherosclerosis.2009.04.033
51. Madsen M., Møller H. J., Nielsen M. J., Jacobsen C., Graversen J. H., Van Den Berg T., Moestrup S. K., Molecular characterization of the haptoglobin-hemoglobin receptor CD163: ligand binding properties of the scavenger receptor cysteine-rich domain region. Journal of Biological Chemistry 2004 279 49 51561 51567 2-s2.0-10944261319 10.1074/jbc.M409629200
52. Schaer C. A., Schoedon G., Imhof A., Kurrer M. O., Schaer D. J., Constitutive endocytosis of CD163 mediates hemoglobin-heme uptake and determines the noninflammatory and protective transcriptional response of macrophages to hemoglobin. Circulation Research 2006 99 9 943 950 2-s2.0-33750451990 10.1161/01.RES.0000247067.34173.1b
53. Schaer D. J., Schaer C. A., Buehler P. W., Boykins R. A., Schoedon G., Alayash A. I., Schaffner A., CD163 is the macrophage scavenger receptor for native and chemically modified hemoglobins in the absence of haptoglobin. Blood 2006 107 1 373 380 2-s2.0-30144435054 10.1182/blood-2005-03-1014
54. Etzerodt A., Kjolby M., Nielsen M. J., Maniecki M., Svendsen P., Moestrup S. K., Plasma clearance of hemoglobin and haptoglobin in mice and effect of CD163 gene targeting disruption. Antioxidants & Redox Signaling 2012 18 17 2254 2263
55. Philippidis P., Mason J. C., Evans B. J., Nadra I., Taylor K. M., Haskard D. O., Landis R. C., Hemoglobin scavenger receptor CD163 mediates interleukin-10 release and heme oxygenase-1 synthesis: antiinflammatory monocyte-macrophage responses in vitro, in resolving skin blisters in vivo, and after cardiopulmonary bypass surgery. Circulation Research 2004 94 1 119 126 2-s2.0-0347951196 10.1161/01.RES.0000109414.78907.F9
56. Fabriek B. O., Polfliet M. M. J., Vloet R. P. M., Van Der Schors R. C., Ligtenberg A. J. M., Weaver L. K., Geest C., Matsuno K., Moestrup S. K., Dijkstra C. D., Van Den Berg T. K., The macrophage CD163 surface glycoprotein is an erythroblast adhesion receptor. Blood 2007 109 12 5223 5229 2-s2.0-34249982324 10.1182/blood-2006-08-036467
57. Fabriek B. O., Bruggen R. V., Deng D. M., Ligtenberg A. J. M., Nazmi K., Schornagel K., Vloet R. P. M., Dijkstra C. D., Van Den Berg T. K., The macrophage scavenger receptor CD163 functions as an innate immune sensor for bacteria. Blood 2009 113 4 887 892 2-s2.0-59649120353 10.1182/blood-2008-07- 167064
58. Bover L. C., Cardó-Vila M., Kuniyasu A., Sun J., Rangel R., Takeya M., Aggarwal B. B., Arap W., Pasqualini R., A previously unrecognized protein-protein interaction between TWEAK and CD163: potential biological implications. Journal of Immunology 2007 178 12 8183 8194 2-s2.0-34250211507
59. Llaurado G., González-Clemente J. M., Maymó-Masip E., Subías D., Vendrell J., Chacón M. R., Serum levels of TWEAK and scavenger receptor CD163 in type 1 diabetes mellitus: relationship with cardiovascular risk factors. a case-control study. PLoS ONE 2012 7 8 e43919
60. Urbonaviciene G., Martin-Ventura J. L., Lindholt J. S., Urbonavicius S., Moreno J. A., Egido J., Blanco-Colio L. M., Impact of soluble TWEAK and CD163/TWEAK ratio on long-term cardiovascular mortality in patients with peripheral arterial disease. Atherosclerosis 2011 219 2 892 899
61. Sánchez-Torres C., Gómez-Puertas P., Gómez-Del-Moral M., Alonso F., Escribano J. M., Ezquerra A., Domínguez J., Expression of porcine CD163 on monocytes/macrophages correlates with permissiveness to African swine fever infection. Archives of Virology 2003 148 12 2307 2323 2-s2.0-0348196692 10.1007/s00705-003-0188-4
62. Welch S. K. W., Calvert J. G., A brief review of CD163 and its role in PRRSV infection. Virus Research 2010 154 1-2 98 103 2-s2.0-78649319822 10.1016/j.virusres.2010.07.018
63. Belcher J. D., Beckman J. D., Balla G., Balla J., Vercellotti G., Heme degradation and vascular injury. Antioxidants and Redox Signaling 2010 12 2 233 248 2-s2.0-77949496427 10.1089/ars.2009.2822
64. Hvidberg V., Maniecki M. B., Jacobsen C., Højrup P., Møller H. J., Moestrup S. K., Identification of the receptor scavenging hemopexin-heme complexes. Blood 2005 106 7 2572 2579 2-s2.0-27144551314 10.1182/blood-2005-03- 1185
65. Moestrup S. K., Gliemann J., Pallesen G., Distribution of the 2-macroglobulin receptor/low density lipoprotein receptor-related protein in human tissues. Cell and Tissue Research 1992 269 3 375 382 2-s2.0-0026731852
66. Tolosano E., Fagoonee S., Hirsch E., Berger F. G., Baumann H., Silengo L., Altruda F., Enhanced splenomegaly and severe liver inflammation in haptoglobin/hemopexin double-null mice after acute hemolysis. Blood 2002 100 12 4201 4208 2-s2.0-0036893587 10.1182/blood-2002-04-1270
67. Fruitier I., Garreau I., Lacroix A., Cupo A., Piot J. M., Proteolytic degradation of hemoglobin by endogenous lysosomal proteases gives rise to bioactive peptides: hemorphins. The FEBS Letters 1999 447 1 81 86 2-s2.0-0032974250 10.1016/S0014-5793(99)00271-9
68. Wang C. Y., Chau L. Y., Heme oxygenase-1 in cardiovascular diseases: molecular mechanisms and clinical perspectives. Chang Gung Medical Journal 2010 33 1 13 24 2-s2.0-77649204284
69. Wu M. L., Ho Y. C., Lin C. Y., Yet S. F., Heme oxygenase-1 in inflammation and cardiovascular disease. American Journal of Cardiovascular Disease 2011 1 2 150 158
70. Hayashi S., Omata Y., Sakamoto H., Higashimoto Y., Hara T., Sagara Y., Noguchi M., Characterization of rat heme oxygenase-3 gene. Implication of processed pseudogenes derived from heme oxygenase-2 gene. Gene 2004 336 2 241 250 2-s2.0-3042799349 10.1016/j.gene.2004.04.002
71. Mccoubrey W. K., Huang T. J., Maines M. D., Isolation and characterization of a cDNA from the rat brain that encodes hemoprotein heme oxygenase-3. European Journal of Biochemistry 1997 247 2 725 732 2-s2.0-8544246393
72. Yoshida T., Sato M., Posttranslational and direct integration of heme oxygenase into microsomes. Biochemical and Biophysical Research Communications 1989 163 2 1086 1092 2-s2.0-0024431214
73. Jung N. H., Kim H. P., Kim B. R., Cha S. H., Kim G. A., Ha H., Na Y. E., Cha Y. N., Evidence for heme oxygenase-1 association with caveolin-1 and -2 in mouse mesangial cells. IUBMB Life 2003 55 9 525 532 2-s2.0-0344012607 10.1080/15216540310001620968
74. Delaby C., Rondeau C., Pouzet C., Willemetz A., Pilard N., Desjardins M., Canonne-Hergaux F., Subcellular localization of iron and heme metabolism related proteins at early stages of erythrophagocytosis. PLoS ONE 2012 7 7 e42199
75. Lin Q., Weis S., Yang G., Weng Y. H., Helston R., Rish K., Smith A., Bordner J., Polte T., Gaunitz F., Dennery P. A., Heme oxygenase-1 protein localizes to the nucleus and activates transcription factors important in oxidative stress. Journal of Biological Chemistry 2007 282 28 20621 20633 2-s2.0-34547135735 10.1074/jbc.M607954200
76. Unno M., Matsui T., Ikeda-Saito M., Structure and catalytic mechanism of heme oxygenase. Natural Product Reports 2007 24 3 553 570 2-s2.0-34249803283 10.1039/b604180a
77. Unno M., Matsui T., Ikeda-Saito M., Crystallographic studies of heme oxygenase complexed with an unstable reaction intermediate, verdoheme. Journal of Inorganic Biochemistry 2012 113 102 109
78. Matsui T., Nakajima A., Fujii H., Matera K. M., Migita C. T., Yoshida T., Ikeda-Saito M., O2- and H2O2-dependent verdoheme degradation by heme oxygenase: reaction mechanisms and potential physiological roles of the dual pathway degradation. Journal of Biological Chemistry 2005 280 44 36833 36840 2-s2.0-27744467540 10.1074/jbc.M503529200
79. Linnenbaum M., Busker M., Kraehling J. R., Behrends S., Heme oxygenase isoforms differ in their subcellular trafficking during hypoxia and are differentially modulated by cytochrome P450 reductase. PLoS ONE 2012 7 4 e35483
80. Ryter S. W., Alam J., Choi A. M. K., Heme oxygenase-1/carbon monoxide: from basic science to therapeutic applications. Physiological Reviews 2006 86 2 583 650 2-s2.0-33645945014 10.1152/physrev.00011.2005
81. Hartsfield C. L., Alam J., Choi A. M. K., Differential signaling pathways of HO-1 gene expression in pulmonary and systemic vascular cells. American Journal of Physiology 1999 277 6 L1133 L1141 2-s2.0-0033370832
82. Alam J., Shibahara S., Smith A., Transcriptional activation of the heme oxygenase gene by heme and cadmium in mouse hepatoma cells. Journal of Biological Chemistry 1989 264 11 6371 6375 2-s2.0-0024516371
83. Applegate L. A., Noel A., Vile G., Frenk E., Tyrrell R. M., Two genes contribute to different extents to the heme oxygenase enzyme activity measured in cultured human skin fibroblasts and keratinocytes: implications for protection against oxidant stress. Photochemistry and Photobiology 1995 61 3 285 291 2-s2.0-0029257545
84. Rizzardini M., Carelli M., Cabello Porras M. R., Cantoni L., Mechanisms of endotoxin-induced haem oxygenase mRNA accumulation in mouse liver: synergism by glutathione depletion and protection by N-acetylcysteine. Biochemical Journal 1994 304 2 477 483 2-s2.0-0028143361
85. Stuhlmeier K. M., Activation and regulation of Hsp32 and Hsp70. European Journal of Biochemistry 2000 267 4 1161 1167 2-s2.0-0033977896 10.1046/j.1432-1327.2000.01112.x
86. Callahan K. S., Effect of tumor necrosis factor-a and interleukin-la on heme oxygenase-1 expression in human endothelial cells. American Journal of Physiology 1998 274 3, part 2 H883 H891 2-s2.0-33746665900
87. Foresti R., Clark J. E., Green C. J., Motterlini R., Thiol compounds interact with nitric oxide in regulating heme oxygenase-1 induction in endothelial cells: involvement of superoxide and peroxynitrite anions. Journal of Biological Chemistry 1997 272 29 18411 18417 2-s2.0-0030875968 10.1074/jbc.272.29.18411
88. Surh Y. J., Kundu J. K., Na H. K., Nrf2 as a master redox switch in turning on the cellular signaling involved in the induction of cytoprotective genes by some chemopreventive phytochemicals. Planta Medica 2008 74 13 1526 1539 2-s2.0-56249106571 10.1055/s-0028-1088302
89. Lee T. S., Chau L. Y., Heme oxygenase-1 mediates the anti-inflammatory effect of interleukin-10 in mice. Nature Medicine 2002 8 3 240 246 2-s2.0-0036127426 10.1038/nm0302-240
90. Kyriakis J. M., Avruch J., Mammalian MAPK signal transduction pathways activated by stress and inflammation: a 10-year update. Physiological Reviews 2012 92 2 689 737
91. Hill-Kapturczak N., Voakes C., Garcia J., Visner G., Nick H. S., Agarwal A., A cis-acting region regulates oxidized lipid-mediated induction of the human heme oxygenase-1 gene in endothelial cells. Arteriosclerosis, Thrombosis, and Vascular Biology 2003 23 8 1416 1422 2-s2.0-0042734437 10.1161/01.ATV. 0000081656.76378.A7
92. Sikorski E. M., Hock T., Hill-Kapturczak N., Agarwal A., The story so far: molecular regulation of the heme oxygenase-1 gene in renal injury. American Journal of Physiology 2004 286 3 F425 F441 2-s2.0-1242284460
93. Choi A. M. K., Alam J., Heme oxygenase-1: function, regulation, and implication of a novel stress-inducible protein in oxidant-induced lung injury. American Journal of Respiratory Cell and Molecular Biology 1996 15 1 9 19 2-s2.0-0030188587
94. Chapple S. J., Siow R. C., Mann G. E., Crosstalk between Nrf2 and the proteasome: therapeutic potential of Nrf2 inducers in vascular disease and aging. International Journal of Biochemistry & Cell Biology 2012 44 8 1315 1320
95. Itoh K., Mimura J., Yamamoto M., Discovery of the negative regulator of Nrf2, keap1: a historical overview. Antioxidants and Redox Signaling 2010 13 11 1665 1678 2-s2.0-77958125017 10.1089/ars.2010.3222
96. Yu R., Chen C., Mo Y. Y., Hebbar V., Owuor E. D., Tan T. H., Kong A. N. T., Activation of mitogen-activated protein kinase pathways induces antioxidant response element-mediated gene expression via a Nrf2-dependent mechanism. Journal of Biological Chemistry 2000 275 51 39907 39913 2-s2.0-0034704079 10.1074/jbc.M004037200
97. Alam J., Wicks C., Stewart D., Gong P., Touchard C., Otterbein S., Choi A. M. K., Burow M. E., Tou J. S., Mechanism of heme oxygenase-1 gene activation by cadmium in MCF-7 mammary epithelial cells: role of p38 kinase and Nrf2 transcription factor. Journal of Biological Chemistry 2000 275 36 27694 27702 2-s2.0-0034623211 10.1074/jbc.M004729200
98. Yet S. F., Perrella M. A., Layne M. D., Hsieh C. M., Maemura K., Kobzik L., Wiesel P., Christou H., Kourembanas S., Lee M. E., Hypoxia induces severe right ventricular dilatation and infarction in heine oxygenase-1 null mice. Journal of Clinical Investigation 1999 103 8 R23 R29 2-s2.0-0033561224
99. Yet S. F., Layne M. D., Liu X., Chen Y. H., Ith B., Sibinga N. E., Perrella M. A., Absence of heme oxygenase-1 exacerbates atherosclerotic lesion formation and vascular remodeling. The FASEB Journal 2003 17 12 1759 1761 2-s2.0-0141706806
100. Ishikawa K., Sugawara D., Wang X. P., Suzuki K., Itabe H., Maruyama Y., Lusis A. J., Heme oxygenase-1 inhibits atherosclerotic lesion formation in LDL-receptor knockout mice. Circulation Research 2001 88 5 506 512 2-s2.0-0035896220
101. Liu X., Wei J., Peng D. H., Layne M. D., Yet S. F., Absence of heme oxygenase-1 exacerbates myocardial ischemia/reperfusion injury in diabetic mice. Diabetes 2005 54 3 778 784 2-s2.0-14644400430 10.2337/diabetes.54.3.778
102. Zuckerbraun B. S., Billiar T. R., Otterbein S. L., Kim P. K. M., Liu F., Choi A. M. K., Bach F. H., Otterbein L. E., Carbon monoxide protects against liver failure through nitric oxide-induced heme oxygenase 1. Journal of Experimental Medicine 2003 198 11 1707 1716 2-s2.0-0344737602 10.1084/jem.20031003
103. Ke B., Kupiec-Weglinski J. W., Buelow R., Shen X. D., Melinek J., Amersi F., Gao F., Ritter T., Volk H. D., Busuttil R. W., Heme oxygenase 1 gene transfer prevents CD95/Fas ligand-mediated apoptosis and improves liver allograft survival via carbon monoxide signaling pathway. Human Gene Therapy 2002 13 10 1189 1199 2-s2.0-0036019201 10.1089/104303402320138970
104. Otterbein L. E., Kolls J. K., Mantell L. L., Cook J. L., Alam J., Choi A. M. K., Exogenous administration of heme oxygenase-1 by gene transfer provides protection against hyperoxia-induced lung injury. Journal of Clinical Investigation 1999 103 7 1047 1054 2-s2.0-0032900940
105. Johnson R. A., Teran F. J., Durante W., Peyton K. J., Johnson F. K., Enhanced heme oxygenase-mediated coronary vasodilation in Dahl salt-sensitive hypertension. American Journal of Hypertension 2004 17 1 25 30 2-s2.0-0346689986 10.1016/j.amjhyper.2003.08.009
106. Gullotta F., di Masi A., Coletta M., Ascenzi P., CO metabolism, sensing, and signaling. Biofactors 2012 38 1 1 13
107. Ryter S. W., Otterbein L. E., Carbon monoxide in biology and medicine. BioEssays 2004 26 3 270 280 2-s2.0-1542314436 10.1002/bies.20005
108. Pae H. O., Son Y., Kim N. H., Jeong H. J., Chang K. C., Chung H. T., Role of heme oxygenase in preserving vascular bioactive NO. Nitric Oxide 2010 23 4 251 257 2-s2.0-77958150583 10.1016/j.niox.2010.08.002
109. Williams S. E., Brazier S. P., Baban N., Telezhkin V., Müller C. T., Riccardi D., Kemp P. J., A structural motif in the C-terminal tail of slo1 confers carbon monoxide sensitivity to human BKCa channels. Pflugers Archiv European Journal of Physiology 2008 456 3 561 572 2-s2.0-43149105180 10.1007/s00424-007-0439-4
110. Otterbein L. E., Bach F. H., Alam J., Soares M., Lu H. T., Wysk M., Davis R. J., Flavell R. A., Choi A. M. K., Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway. Nature Medicine 2000 6 4 422 428 2-s2.0-0034071424 10.1038/74680
111. Hoetzel A., Dolinay T., Vallbracht S., Zhang Y., Hong P. K., Ifedigbo E., Alber S., Kaynar A. M., Schmidt R., Ryter S. W., Choi A. M. K., Carbon monoxide protects against ventilator-induced lung injury via PPAR- γ and inhibition of Egr-1. American Journal of Respiratory and Critical Care Medicine 2008 177 11 1223 1232 2-s2.0-44449171400 10.1164/rccm.200708-1265OC
112. Dolinay T., Wu W., Kaminski N., Ifedigbo E., Kaynar A. M., Szilasi M., Watkins S. C., Ryter S. W., Hoetzel A., Choi A. M. K., Mitogen-activated protein kinases regulate susceptibility to ventilator-induced lung injury. PLoS ONE 2008 3 2 2-s2.0-45449120100 10.1371/journal.pone.0001601 e1601
113. Gajdócsy R., Horváth I., Exhaled carbon monoxide in airway diseases: from research findings to clinical relevance. Journal of Breath Research 2010 4 4 2-s2.0-78649879857 10.1088/1752-7155/4/4/047102 047102
114. Baranano D. E., Wolosker H., Bae B. I., Barrow R. K., Snyder S. H., Ferris C. D., A mammalian iron ATPase induced by iron. Journal of Biological Chemistry 2000 275 20 15166 15173
115. Yachie A., Niida Y., Wada T., Igarashi N., Kaneda H., Toma T., Ohta K., Kasahara Y., Koizumi S., Oxidative stress causes enhanced endothelial cell injury in human heme oxygenase-1 deficiency. Journal of Clinical Investigation 1999 103 1 129 135 2-s2.0-0032893958
116. Poss K. D., Tonegawa S., Heme oxygenase 1 is required for mammalian iron reutilization. Proceedings of the National Academy of Sciences of the United States of America 1997 94 20 10919 10924 2-s2.0-0030886381 10.1073/pnas.94.20. 10919
117. Eisenstein R. S., Munro H. N., Translational regulation of ferritin synthesis by iron. Enzyme 1990 44 1-4 42 58 2-s2.0-0025586420
118. Vile G. F., Tyrrell R. M., Oxidative stress resulting from ultraviolet A irradiation of human skin fibroblasts leads to a heme oxygenase-dependent increase in ferritin. Journal of Biological Chemistry 1993 268 20 14678 14681 2-s2.0-0027255106
119. Berberat P. O., Katori M., Kaczmarek E., Anselmo D., Lassman C., Ke B., Shen X., Busuttil R. W., Yamashita K., Csizmadia E., Tyagi S., Otterbein L. E., Brouard S., Tobiasch E., Bach F. H., Kupiec-Weglinski J. W., Soares M. P., Heavy chain ferritin acts as an antiapoptotic gene that protects livers from ischemia reperfusion injury. The FASEB Journal 2003 17 12 1724 1726 2-s2.0-0141818109
120. Vile G. F., Basu-Modak S., Waltner C., Tyrrell R. M., Heme oxygenase 1 mediates an adaptive response to oxidative stress in human skin fibroblasts. Proceedings of the National Academy of Sciences of the United States of America 1994 91 7 2607 2610 2-s2.0-0028300334
121. Kapitulnik J., Maines M. D., The role of bile pigments in health and disease: effects on cell signaling, cytotoxicity, and cytoprotection. Frontiers in Pharmacology 2012 3 136
122. Vitek L., The role of bilirubin in diabetes, metabolic syndrome, and cardiovascular diseases. Frontiers in Pharmacology 2012 3 55
123. Stocker R., Antioxidant activities of bile pigments. Antioxidants and Redox Signaling 2004 6 5 841 849 2-s2.0-4544386856 10.1089/ars.2004.6.841
124. Jansen T., Daiber A., Direct antioxidant properties of bilirubin and biliverdin. Is there a role for biliverdin reductase? Frontiers in Pharmacology 2012 3 30
125. Wegiel B., Otterbein L. E., Go green: the anti-inflammatory effects of biliverdin reductase. Frontiers in Pharmacology 2012 3 47